T/CMEAS 001-2022 Active Group standards

T/CMEAS 001-2022 Microinjection technology guideline

T/CMEAS 001-2022 Microinjection technology guideline

Publish Date: 2022-11-01 Implement Date: 2022-11-01 For services related to genuine standard inquiry, procurement, translation, and other related services in China, please Contact Us
Price: $ 20.00
Out of stock

Basic Information

Standard Code: T/CMEAS 001-2022
Standard Type: Group standards
Standard Status: Active
is_force_gb: no
CCS Name: -
ICS Name: Integrated medical science and healthcare devices
Publish Date: 2022-11-01
Implement Date: 2022-11-01

Scope

Main technical content: Microtransplantation is a treatment method that combines traditional chemotherapy with hematopoietic stem cell transplantation immunity. The main technical content includes donor selection and hematopoietic stem cell donation and preparation, patient screening and chemotherapy, microtransplantation-related supportive treatment and complication management, microtransplantation-related laboratory detection items and monitoring programs, etc. The donor donation part refers to the physical examination and mobilization collection standards for hematopoietic stem cell transplantation donors, and is only limited by the specific needs of microtransplantation in donor selection; the patient chemotherapy part refers to the recommended regimens of NCCN, LEN and domestic experts' consensus, and according to the different states of patients, it is recommended to choose different drugs or doses of the regimen; the team standard also formulates the treatment methods of microtransplantation-related complications and efficacy monitoring programs, so that users can better grasp and use this technology

Development Information

Related Standards

Contact Us